Efficacy and safety of febuxostat for treating hyperuricemia in patients with chronic kidney disease and in renal transplant recipients: A systematic review and meta-analysis

Febuxostat is potent and well-tolerated in the management of chronic gout. However, its clinical efficacy and safety in the treatment of hyperuricemia in patients with chronic kidney disease (CKD) and in renal transplant recipients have remained to be fully determined. The MEDLINE, EMBASE and Cochra...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuzhong, Liu, Kun, Sun, Qing, Wang, Yunyan, Meng, Junsong, Xu, Zongyuan, Shi, Zhaofei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122173/
https://www.ncbi.nlm.nih.gov/pubmed/30186411
http://dx.doi.org/10.3892/etm.2018.6367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122173/
https://www.ncbi.nlm.nih.gov/pubmed/30186411
http://dx.doi.org/10.3892/etm.2018.6367

Ejemplares similares